ALLERGY TO SULFONAMIDE INCREASES RISK OF PNEUMOCYSTIS JIROVECI PNEUMONIA (PJP) IN BONE MARROW TRANSPLANT PATIENTS

被引：0
|
作者：
Khan, B.
Ahmad, A.
Henao, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P233
引用
收藏
页码：S77 / S78
页数：2
相关论文
共 50 条
  • [1] Pneumocystis jiroveci Pneumonia (PJP) in a Renal Transplant Patient: Diagnostic and Management Difficulties
    Vakil, Abhay
    Okhotin, Helena
    Upadhyay, Hineshkumar
    Sherani, Khalid
    Cervellione, Kelly
    Fein, Alan
    CHEST, 2013, 144 (04)
  • [2] Risk Factors of Pneumocystis Jiroveci Pneumonia (PJP) in Patients with RA and Sulfasalazine As a Possible Protective Agent
    Motojima, Shinji
    Nakashita, Tamao
    Jibatake, Akira
    Yoshida, Akira
    Yamamoto, Yoshiki
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Pneumocystis jiroveci pneumonia (PJP) in non-HIV immunocompromised individuals
    Schoovaerts, Kathleen
    Dirix, Luc
    Rutten, Annemie
    Van Schaeren, Jef
    Van Herendael, Bruno
    Van Grieken, Sofie
    Heytens, Luc
    ACTA CLINICA BELGICA, 2017, 72 (06) : 413 - 416
  • [4] Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients
    Tachibana, Sayaka
    Inoue, Koji
    Siojiri, Masaaki
    Nakanishi, Norihiko
    Moritaka, Tomonori
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] Clindamycin–primaquine for pneumocystis jiroveci pneumonia in renal transplant patients
    P. Nickel
    M. Schürmann
    H. Albrecht
    R. Schindler
    K. Budde
    T. Westhoff
    J. Millward
    N. Suttorp
    P. Reinke
    D. Schürmann
    Infection, 2014, 42 : 981 - 989
  • [6] PREVALENCE OF PNEUMOCYSTIS JIROVECI PNEUMONIA(PJP)IN PATIENTS WITH RHEUMATOLOGICAL CONDITIONS ON IMMUNOSUPPRESSIVE MEDICATIONS AND THE NEED FOR PROPHYLAXIS
    Ramachandran, D.
    Mushtaq, W.
    Makkuni, D.
    Reddy, H.
    Paget, James
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2072 - 2072
  • [7] Does Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Prevent Hospitalizations for Other Infections in Vasculitis Patients?
    Patel, Veena
    Trotter, Kim
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients
    Eitner, Frank
    Hauser, Ingeborg A.
    Rettkowski, Olaf
    Rath, Thomas
    Lopau, Kai
    Pliquett, Rainer U.
    Fiedler, Roman
    Guba, Markus
    Hilgers, Ralf-Dieter
    Floege, Juergen
    Fischereder, Michael
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (06) : 2013 - 2017
  • [9] Pneumocystis jiroveci Pneumonia (PJP) in Kidney and Pancreas Transplant Recipients in the Present Era of Routine Post-Transplant Prophylaxis: Risk Factors and Outcomes.
    Garg, N.
    Jorgenson, M.
    Birschbach, M.
    Descourouez, J.
    Parajuli, S.
    Astor, B.
    Djamali, A.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 418 - 418
  • [10] A Tale of Immunosuppression: Pneumocystis Jiroveci Pneumonia (PJP) in a Patient on Ruxolitinib for a Hematologic Disorder
    Alpizar-Rivas, R. M.
    Mo, J.
    Georas, S. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345